Crown Baus Capital logo

CBCA - Crown Baus Capital News Story

$0.33 0.0  0.0%

Last Trade - 13/08/20

Sector
Industrials
Size
Micro Cap
Market Cap £36.3m
Enterprise Value £36.3m
Revenue £n/a
Position in Universe th / 6380

Crown Baus Launches iCannabinoid Marketplace for Cannabis Science; Live Negotiating Platform to Revolutionize How the Medical Cannabis Industry Buys and Sells Equipment and Supplies

Fri 7th September, 2018 5:45pm
Crown Baus Launches iCannabinoid Marketplace for Cannabis Science; Live Negotiating Platform to Revolutionize How the Medical Cannabis Industry Buys and Sells Equipment and Supplies

Beverly Hills, CA, Sept. 07, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate with investments primarily in five industries – High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services – is pleased to announce the beta launch of iCannabinoid Marketplace, an online, real-time, live negotiating platform for Cannabis Science, Inc. (OTC: CBIS).

The iCannabinoid Marketplace uses real-time, streaming technology to provide users with the ability to instantly find and negotiate with buyers and sellers of medical marijuana equipment and supplies worldwide. The Marketplace will be available 24 hours a day, and will provide real-time, live inventory updating capabilities, as well as an instant private negotiating environment. iCannabinoid Marketplace will provide a secure platform, and all buyers and sellers will be able to negotiate live, via this platform, choosing currencies from around the world. The system will provide private, one-on-one, and one-to-many negotiations while dynamically loading and matching inventory changes and instantly updating new opportunities. iCannabinoid Marketplace will also help registered users reach optimum market prices for equipment and supplies, without compromising the seller's proprietary pricing information or identity, if they so choose.

For this Beta Launch, Crown Baus has removed all the associated Company fees. There will be no per transaction fees, no monthly fees, and no order entry fees. iCannabinoid Marketplace will be completely free for the public to use during the beta testing phase. Crown Baus encourages users to register and test the marketplace. The Company encourages buyers and sellers to list items for sale, find and comment on any bugs experienced during this beta phase, suggest any new categories to add, and find opportunities and products of interest. 

To register to buy or sell products, please visit https://marketplace.icannabinoid.com

“We believe that the technology infused into iCannabinoid Marketplace is a game-changer,” stated Mr. Raymond C. Dabney, Crown Baus Capital’s President, Chief Executive Officer (CEO), and Co-founder. “This new and exciting platform will change how medical cannabis equipment and supplies are bought and sold worldwide. My understanding is that there is still no comparable live-negotiating technology in the marketplace today. This represents a tremendous opportunity for Crown Baus, Cannabis Science, and all our shareholders.” 

Crown Baus Capital specializes in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups. Crown Baus recently acquired the rights to develop the technology from Mr. Raymond C. Dabney, the owner and designer of the original technology used by XRAYMEDIA. 

XRAYMEDIA disrupted the media and advertising industries by providing media professionals, business owners, executives, and entrepreneurs throughout the world with a centralized media marketplace via its Live Media Marketplace (LMM) tool. The LMM was developed by XRAYMEDIA with the advice and support of a number of major, multinational corporations, including members of  the American Association of Advertising Agencies back in early 2000. Several versions of LMM were developed by Mr. Dabney in addition to the LMM Advertising Version. Other versions of LMM technology were developed for several industries and activities, including the automobile industry, real estate negotiations, along with several other industries to be released shortly with several new partnership opportunities.

“Here we go! Fasten your seatbelts! This technology is the most advanced, robust, real-time transactional software I have ever seen,” added Mr. Dabney. “It has a number of commercial applications and Crown Baus will roll-out the technology redesigned for each industry of interest, including major business opportunities designed to create an economic boost for the general public and local businesses in any jurisdiction worldwide.”

Crown Baus’ Live Negotiating Technology has been redesigned, and it is ready for successful implementation. The Company’s development team has worked successfully to prepare for this beta launch while leveraging this technology to create new and exciting opportunities for the Company and its partners in many different industries.  

“We are quite certain that over the next few weeks we will complete our Beta testing phase and begin the full commercialization process. Register now and participate! We will provide some outstanding opportunities and bonuses for all those who participated in our Beta Testing Phase. Have fun!” concluded Mr. Dabney.

iCannabinoid is a state-of-the-art, high technology social media and educational website recently launched by Cannabis Science, Inc. (OTC: CBIS). iCannabinoid is the premier online platform for all things cannabinoid-related, and creates a community of patients, doctors, researchers, parents, lawyers, growers, journalists, government and private-sector leaders, community organizers, and other interested parties. iCannabinoid serves as an information center, resource hub, and support group for those seeking alternative cannabinoid treatments for various critical ailments. For information in iCannabinoid, visit www.icannabinoid.com.

About Crown Baus Capital Corporation

Crown Baus Capital Corporation is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services. The Company specializes in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups, to create synergistic savings and increased value to our shareholders.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition. Crown Baus Capital Corporation does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.


Contact

Crown Baus Capital Corporation
Raymond C. Dabney
President & CEO, Co-Founder
T: +1 (888) 263-0948
info@crownbaus.com

© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.